IRIS
VAGHI, GLORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 162
EU - Europa 151
AS - Asia 49
Totale 362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 161
IE - Irlanda 62
IT - Italia 42
CN - Cina 25
SG - Singapore 18
DE - Germania 17
FI - Finlandia 15
AT - Austria 5
JP - Giappone 4
NL - Olanda 3
FR - Francia 2
GB - Regno Unito 2
CA - Canada 1
CZ - Repubblica Ceca 1
IN - India 1
LU - Lussemburgo 1
LV - Lettonia 1
TH - Thailandia 1
Totale 362
Salva come PNG Salva come JPEG
Città #
Dublin 62
Chandler 51
Boardman 18
Helsinki 15
Ashburn 14
Milan 13
Singapore 13
Shanghai 12
Munich 8
Rome 8
Lawrence 6
Medford 6
New York 6
Princeton 6
Los Angeles 4
Tokyo 4
Cremona 3
Piscataway 3
Seveso 3
Wilmington 3
Beijing 2
Cormano 2
La Tronche 2
London 2
Torino 2
Vienna 2
Amsterdam 1
Bangkok 1
Brno 1
Castegnato 1
Fayetteville 1
Frankfurt am Main 1
Germantown 1
Luxembourg 1
Marghera 1
Norwalk 1
Pune 1
Riga 1
Saronno 1
Seattle 1
Shijiazhuang 1
Toronto 1
Woodbridge 1
Xi'an 1
Totale 288
Salva come PNG Salva come JPEG
Nome #
Correlation of frontal atrophy and CSF tau levels with neuropsychiatric symptoms in patients with cognitive impairment: a memory clinic experience 63
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 39
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 37
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 33
BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in the CLINICAL PICTURE of DEMENTIA 33
Potential Contribution of Hypertension to Evolution of Chronic Migraine and Related Mechanisms 32
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 32
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 29
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 14
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 13
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 12
Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview 12
null 11
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 8
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 6
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 6
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches 5
Who cares about migraine? Pathways and hurdles in the European region - access to care III 5
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 5
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 4
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 2
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 2
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 2
Redefining migraine prevention: Early treatment with anti-CGRP monoclonal antibodies enhances response in the real world 2
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 1
Totale 408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.658
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 12 6 1 0 2
2021/202221 0 0 0 0 0 0 0 3 1 3 1 13
2022/2023151 13 11 0 10 13 11 2 13 68 3 6 1
2023/202494 7 10 2 1 8 12 2 15 1 6 14 16
2024/2025121 11 13 9 2 11 71 4 0 0 0 0 0
Totale 408